Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 6 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 2 business days late.
The 10 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Sep 18 | ABUS | Arbutus Biopharma Corp | MEXER◆ | 52,533 | — | — | — | Open the original filing on SEC.gov |
| Sep 18 | ABUS | Arbutus Biopharma Corp | FTAX | 100,508 | $5.07 | $509.6K | -76.5% | Open the original filing on SEC.gov |
| Sep 18 | ABUS | Arbutus Biopharma Corp | MEXER | 78,800 | $4.24 | $334.1K | +150.0% | Open the original filing on SEC.gov |
| Sep 18 | ABUS | Arbutus Biopharma Corp | MEXER | 52,533 | $3.34 | $175.5K | — | Open the original filing on SEC.gov |
| Jun 8 | ABUS | Arbutus Biopharma Corp | AGRANT◆ | 78,800 | — | — | — | Open the original filing on SEC.gov |
| May 21 | ACTU | Actuate Therapeutics, INC. | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 4, 2025 | ABUS | Arbutus Biopharma Corp | AGRANT◆ | 157,600 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | ACTU | Actuate Therapeutics, INC. | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |